Markets
GSK

Health Care Sector Update for 03/29/2016: GSK, CTRV

Top Health-care stocks:

JNJ: -0.1%

PFE: -0.3%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade on Tuesday.

In health-care stocks news, ADRs of GlaxoSmithKline ( GSK ) were edging higher pre-market Tuesday after Japanese authorities granted marketing authorization for Nucala as a treatment for bronchial asthma in patients with refractory asthma.

ADRs were 0.2% higher at $39.61 pre-bell. The stock has traded between $37.24 and $48.45 over the past 52 weeks.

ContraVir Pharmaceuticals Inc ( CTRV ) shares were higher in recent pre-market trade after the company said that results from a third party in vitro study validates the company's CMX157 drug as a "highly potent anti-hepatitis B drug."

Shares were 31.5% higher at $1.96 pre-bell. The stock has traded between $0.76 and $6.28 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GSK HEPA

Other Topics

US Markets

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More